Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Hanna Bitner"'
Autor:
Arnon Nagler, Amnon Peled, Eithan Galun, Michal Abraham, Hanna Wald, Lola Weiss, Devorah Olam, Shiri Klein, Elena Ribakovsky, Maya Koren-Michowitz, Merav Leiba, Avichai Shimoni, Hanna Bitner, Evgenia Rosenberg, Katia Beider
Purpose: To explore the functional consequences of possible cross-talk between the CXCR4/CXCL12 and the sphingosine-1-phosphate (S1P) pathways in multiple myeloma (MM) cells and to evaluate the effect of S1P targeting with the FTY720 modulator as a p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca9eb97bd487d7d584a79b6366d3d5c
https://doi.org/10.1158/1078-0432.c.6523479.v1
https://doi.org/10.1158/1078-0432.c.6523479.v1
Autor:
Arnon Nagler, Amnon Peled, Eithan Galun, Michal Abraham, Hanna Wald, Lola Weiss, Devorah Olam, Shiri Klein, Elena Ribakovsky, Maya Koren-Michowitz, Merav Leiba, Avichai Shimoni, Hanna Bitner, Evgenia Rosenberg, Katia Beider
Contains supplementary methods and primer sequences
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::434de27e31bfb93536e2461c24bce701
https://doi.org/10.1158/1078-0432.22457007
https://doi.org/10.1158/1078-0432.22457007
Autor:
Lola Weiss, Valeria Voevoda-Dimenshtein, Avichai Shimoni, Evgenia Rosenberg, Jonathan Canaani, Michal Abraham, Amnon Peled, Hila Magen, Yaarit Sirovsky, Arnon Nagler, Olga Ostrovsky, Noya Shilo, Katia Beider, Michael Milyavsky, Hanna Bitner
Publikováno v:
Biochemical pharmacology. 168
Although having promising anti-myeloma properties, the pan-histone deacetylase inhibitor (HDACi) panobinostat lacks therapeutic activity as a single agent. The aim of the current study was to elucidate the mechanisms underlying multiple myeloma (MM)
Autor:
Amnon Peled, Odit Gutwein, Hanna Wald, Katia Beider, Olga Ostrovsky, Arnon Nagler, Eithan Galun, Maya Koren-Michowitz, Hanna Bitner, Michal Abraham, Merav Leiba
Publikováno v:
Oncotarget
// Katia Beider 1 , Hanna Bitner 1 , Merav Leiba 1 , Odit Gutwein 1 , Maya Koren-Michowitz 1 , Olga Ostrovsky 1 , Michal Abraham 3 , Hanna Wald 3 , Eithan Galun 2 , Amnon Peled 2 and Arnon Nagler 1 1 Hematology Division and CBB, Guy Weinshtock Multip
Autor:
Avichai Shimoni, Amnon Peled, Hila Magen, Evgenia Rosenberg, Hanna Bitner, Katia Beider, Yaarit Sirovsky, Olga Ostrovsky, Valeria Voevoda, Michael Milyavsky, Arnon Nagler
Publikováno v:
Blood. 132:1366-1366
Acquired or de novo resistance to the traditional and novel anti-multiple myeloma (MM) agents remains a major treatment obstacle, therefore novel therapies are in need. Wild-type p53-induced phosphatase 1 (WIP1) is an oncogenic serine/threonine phosp
Autor:
Katia Beider, Valeria Voevoda, Hila Magen, Avichai Shimoni, Hanna Bitner, Olga Ostrovsky, Evgenia Rosenberg, Amnon Peled, Noya Shilo, Arnon Nagler, Michael Milyavsky, Merav Leiba
Publikováno v:
Blood. 128:891-891
Introduction: Multiple myeloma (MM) is a neoplastic disorder that is characterized by clonal proliferation of plasma cells in the bone marrow (BM). Despite the initial efficacious treatment, MM patients often become refractory to common anti-MM drugs
Autor:
Katia Beider, David Naor, Nira Bloom, Avichai Shimoni, Olga Ostrovsky, Hanna Bitner, Valeria Voevoda, Evgenia Rosenberg, Simone Tal, Ivetta Danilesko, Arnon Nagler
Publikováno v:
Blood. 126:1889-1889
Polyclonal anti-human T-lymphocyte immunoglobulin(ATG) have been recently shown, in two randomized studies, to significantly reduce the incidence of graft versus host disease (GVHD) post allogeneic stem cell transplantation (HSCT) from both sibling a
Autor:
Sten Andréasson, Birgit Sander, Stig K. Holfort, Michael Larsen, Patrik Schatz, Hanna Bitner, Dror Sharon
Publikováno v:
Investigative ophthalmologyvisual science. 51(9)
PURPOSE. To analyze retinal structure and function in vitelliform macular dystrophy (VMD) due to mutations in BEST1. METHODS. Patients from five Swedish and four Danish families were examined with electrooculography (EOG), full-field electroretinogra
Autor:
Hanna Wald, Avichai Shimoni, Shiri Klein, Arnon Nagler, Merav Leiba, Evgenia Rosenberg, Michal Abraham, Amnon Peled, Katia Beider, Hanna Bitner, Maya Koren-Michowitz
Publikováno v:
Blood. 124:4707-4707
Introduction: Multiple myeloma (MM) is an incurable hematological malignancy characterized by proliferation of malignant plasma cells in the bone marrow (BM). Interactions between MM cells and BM milieu facilitate disease progression and therapy resi
Publikováno v:
American Journal of Ophthalmology; 154(2), pp 403-412 (2012)
PURPOSE: To estimate the prevalence, genotype, and clinical spectrum of Best vitelliform macular dystrophy (Best disease). DESIGN: Retrospective epidemiologic and clinical and molecular genetic observational study. METHODS: SETTING: National referral